Expression of FOXM1 and related proteins in breast cancer molecular subtypes
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of FOXM1 and related proteins in breast cancer molecular subtypes
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Volume 97, Issue 2, Pages 170-177
Publisher
Wiley
Online
2016-06-09
DOI
10.1111/iep.12187
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes
- (2014) George P. Stathopoulos et al. ANTI-CANCER DRUGS
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer
- (2013) Mattaka Khongkow et al. CARCINOGENESIS
- Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information
- (2013) Linda P Feeley et al. MODERN PATHOLOGY
- Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells
- (2013) Deborah A Sanders et al. GENOME BIOLOGY
- FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair
- (2012) Yun-Yong Park et al. CARCINOGENESIS
- Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer
- (2012) Minqing Wu et al. MEDICAL ONCOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Regulation of FoxO transcription factors by acetylation and protein–protein interactions
- (2011) Hiroaki Daitoku et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis
- (2011) Maria M. Mihaylova et al. CELL
- Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin
- (2011) Ka-Kei Ho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The transcription factor FOXM1 is a cellular target of the natural product thiostrepton
- (2011) Nagaratna S. Hegde et al. Nature Chemistry
- FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
- (2011) C T Karadedou et al. ONCOGENE
- Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM
- (2010) Charles J. Vaske et al. BIOINFORMATICS
- FoxM1 Mediates Resistance to Herceptin and Paclitaxel
- (2010) Janai R. Carr et al. CANCER RESEARCH
- Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma
- (2010) Ho Lee et al. HUMAN PATHOLOGY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. Journal of Oncology Practice
- Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
- (2009) U. B. McGovern et al. MOLECULAR CANCER THERAPEUTICS
- Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer
- (2008) Nuran Bektas et al. BMC CANCER
- Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
- (2008) J. M-M. Kwok et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now